Abstract:A series of novel I,2,4‐oxadiazole sulfonamides were synthesized, characterized, and tested for antimicrobial activity. Compound 8 d emerged as the most potent one on which further antimicrobial studies were performed. Notably this compound demonstrated good antimicrobial activity against both the tested gram positive and negative bacterial strains. In this investigation, we synthesized substituted 1,2,4‐oxadiazole‐sulfonamide conjugates (8 a–8 l) through a multistep synthetic approach. These compounds were then evaluated against six bacterial strains, consisting of three Gram‐positive and three Gram‐negative strains. Among them, compound 8 d displayed notable inhibitory activity, with minimum inhibitory concentration (MIC) values of 64 μg/mL observed against the Gram‐positive bacteria Staphylococcus aureus and Enterococcus faecalis. Notably, in the disk diffusion assay, compound 8 d exhibited the most substantial zone of inhibition (ZOI) against Escherichia coli and S. aureus, with respective ZOI measurements of 14 mm and 15 mm, both at a concentration of 2MIC. Additionally, supplementary investigations, including the Fractional Inhibitory Concentration Index (FICI) provided further support for the inhibitory potential of 8 d against the standard bacterial strains. When combined with Ampicillin (Amp), it demonstrated a synergistic effect, significantly augmenting its antibacterial activity against Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterococcus faecalis. Importantly, it exhibited no toxicity toward human red blood cells (hRBC). Furthermore, The Absorption, Distribution, Metabolism, and Excretion (ADME) profile of 8 d indicated its favorable drug‐like characteristics.

Synthesis of Substituted-Amidine Derivatives of Avibactam and Synergistic Antibacterial Activity with Meropenem

Sulfonylamidine‐substituted Derivatives of Avibactam: Synthesis and Antibacterial Activity

Synthesis and antibacterial activity of novel icariin derivatives.

Substituted-amidine derivatives of diazabicyclooctane as prospective β-lactamase inhibitors

Synergistic Antibacterial Activity of Meropenem and Imipenem in Combination with Diazabicyclooctane Derivatives

Β-Lactamase Inhibition Profile of New Amidine-Substituted Diazabicyclooctanes

Synthesis and Antibacterial Evaluation of Novel Vancomycin Derivatives Containing Quaternary Ammonium Moieties

Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA)

Synthesis and antimicrobial activity of the hybrid molecules between amoxicillin and derivatives of benzoic acid

Synthesis and Biological Evaluation of Aspergillomarasmine A Derivatives As Novel NDM-1 Inhibitor to Overcome Antibiotics Resistance

((S)-3-mercapto-2-methylpropanamido)acetic Acid Derivatives As Metallo-Β-lactamase Inhibitors: Synthesis, Kinetic and Crystallographic Studies.

Synthesis and Β-Lactamase Inhibition Activity of Diazabicyclooctane Derivatives in Combination with Imipenem

Synthesis and Β-Lactamase Inhibition Activity of Imidates of Diazabicyclooctane

Design, synthesis and biological evaluation of amphiphilic benzopyran derivatives as potent antibacterial agents against multidrug-resistant bacteria

Synthesis and antibiofilm evaluation of N-acyl-2-aminopyrimidine derivatives against Acinetobacter baumannii

Synthesis of 1,2,4‐Oxadiazole‐sulfonamide Conjugates and Their Synergistic Effect with Ampicillin as Antimicrobial Agents

Synthesis of peptidomimetics as antibiotic adjuvants for combination with aztreonam to combat MDR Pseudomonas aeruginosa

Discovery of Thiosemicarbazone Derivatives As Effective New Delhi Metallo-Β-lactamase-1 (NDM-1) Inhibitors Against NDM-1 Producing Clinical Isolates.

Synthesis, Characterization and Antibacterial Activity Study of Para‐substituted Derivatives of N ‐benzyl‐3‐methylbuten‐2‐enamides

Design, synthesis and evaluation of the antibacterial enhancement activities of amino dihydroartemisinin derivatives.

Synthesis of 1,3,4-trisubstituted pyrrolidines as meropenem adjuvants targeting New Delhi metallo-β-lactamase